Ourotech competitors

Ourotech Competitors include Cleveland BioLabs, Aeglea Biotherapeutics, Heat Biologics and Immune Design.
Add company...
Ourotech
Ourotech is changing the way cancer drugs are tested for the most innovative treatments.
Cleveland BioLabs
CBLI’s mission is to develop and commercialize innovative drugs to treat cancer and protect healthy tissues from radiation, chemotherapy or ischemic conditions.
Aeglea Biotherapeutics
Aeglea BioTherapeutics is a biotechnology company committed to developing enzyme-based therapeutics in the field of amino acid metabolism to treat rare genetic diseases and cancer.
Heat Biologics
Heat Biologics is a clinical-stage company focused on developing its proprietary “ImPACT” (Immune Pan-Antigen Cytotoxic Therapy) fully allogeneic “off-the-shelf” cell based immunotherapy to treat patients with a wide array of cancers and infectious diseases.
Immune Design
Immune Design develops vaccines and therapeutics for the prevention and treatment of infectious diseases.
Founding Date
Founding Date
2015
Founding Date
2003
Founding Date
2013
Founding Date
2008
Founding Date
2008
Type
Type
Private
Type
Public
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
Waterloo, CA HQ
Locations
Buffalo, US HQ
Locations
Austin, US HQ
Locations
Durham, US HQ
Locations
Seattle, US HQ
South San Francisco, US
Employees
Employees
325% decrease
Employees
1220% decrease
Employees
5011% increase
Employees
19
Employees
5510% increase
Valuation ($)
Valuation ($)
N/A
Valuation ($)
19.5 m
Valuation ($)
189.2 m
Valuation ($)
36.5 m
Valuation ($)
71.3 m
Facebook likes
Facebook likes
504
Facebook likes
32
Facebook likes
N/A
Facebook likes
110
Facebook likes
N/A

Financial

Net income
Net income
N/A
Net income
($9.8m) (FY, 2017)
Net income
($27.2m) (FY, 2017)
Net income
($12.4m) (FY, 2017)
Net income
($51.9m) (FY, 2017)

Operating

Phase I Trials Products
Phase I Trials Products
N/A
Phase I Trials Products
N/A
Phase I Trials Products
2 (FY, 2016)
Phase I Trials Products
N/A
Phase I Trials Products
1 (FY, 2016)
For sources of this data, please see the company profileDownload Excel

View company profiles

Cleveland BioLabs
HQ
Buffalo, US
Employees
12↓ 20% decrease

CBLI’s mission is to develop and commercialize innovative drugs to treat cancer and protect healthy tissues from radiation, chemotherapy or ischemic conditions.

View company
Aeglea Biotherapeutics
HQ
Austin, US
Employees
50↑ 11% increase

Aeglea BioTherapeutics is a biotechnology company committed to developing enzyme-based therapeutics in the field of amino acid metabolism to treat rare genetic diseases and cancer.

View company
Heat Biologics
HQ
Durham, US
Employees
19

Heat Biologics is a clinical-stage company focused on developing its proprietary “ImPACT” (Immune Pan-Antigen Cytotoxic Therapy) fully allogeneic “off-the-shelf” cell based immunotherapy to treat patients with a wide array of cancers and infectious diseases.

View company
Immune Design
HQ
Seattle, US
Employees
55↑ 10% increase

Immune Design develops vaccines and therapeutics for the prevention and treatment of infectious diseases.

View company